Literature DB >> 30267337

Epigenetic influences on genetically triggered thoracic aortic aneurysm.

Stefanie S Portelli1, Elizabeth N Robertson2,3, Cassandra Malecki2, Kiersten A Liddy2, Brett D Hambly2, Richmond W Jeremy2,3.   

Abstract

Genetically triggered thoracic aortic aneurysms (TAAs) account for 30% of all TAAs and can result in early morbidity and mortality in affected individuals. Epigenetic factors are now recognised to influence the phenotype of many genetically triggered conditions and have become an area of interest because of the potential for therapeutic manipulation. Major epigenetic modulators include DNA methylation, histone modification and non-coding RNA. This review examines epigenetic modulators that have been significantly associated with genetically triggered TAAs and their potential utility for translation to clinical practice.

Entities:  

Keywords:  Aortic dilatation; Epigenetics; MicroRNA; Non-coding RNA; Thoracic aortic aneurysm

Year:  2018        PMID: 30267337      PMCID: PMC6233334          DOI: 10.1007/s12551-018-0460-1

Source DB:  PubMed          Journal:  Biophys Rev        ISSN: 1867-2450


  145 in total

1.  Chromosomal silencing and localization are mediated by different domains of Xist RNA.

Authors:  Anton Wutz; Theodore P Rasmussen; Rudolf Jaenisch
Journal:  Nat Genet       Date:  2002-01-07       Impact factor: 38.330

Review 2.  Phenotypic plasticity and the epigenetics of human disease.

Authors:  Andrew P Feinberg
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

3.  Potential role of miR-29b in modulation of Dnmt3a and Dnmt3b expression in primordial germ cells of female mouse embryos.

Authors:  Shuji Takada; Eugene Berezikov; Young Lim Choi; Yoshihiro Yamashita; Hiroyuki Mano
Journal:  RNA       Date:  2009-06-09       Impact factor: 4.942

4.  A microRNA profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in contributing to thoracic aortic dissection pathogenesis.

Authors:  Mingfang Liao; Sili Zou; Jianfeng Weng; Lewei Hou; Lin Yang; Zhiqing Zhao; Junmin Bao; Zaiping Jing
Journal:  J Vasc Surg       Date:  2011-02-18       Impact factor: 4.268

5.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

6.  Increased canonical WNT/β-catenin signalling and myxomatous valve disease.

Authors:  Sunita Chopra; Nadia Al-Sammarraie; Yimu Lai; Mohamad Azhar
Journal:  Cardiovasc Res       Date:  2017-01       Impact factor: 10.787

Review 7.  LncRNAs in vascular biology and disease.

Authors:  Viorel Simion; Stefan Haemmig; Mark W Feinberg
Journal:  Vascul Pharmacol       Date:  2018-02-06       Impact factor: 5.773

Review 8.  Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections.

Authors:  Jay D Humphrey; Martin A Schwartz; George Tellides; Dianna M Milewicz
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

9.  Cytosine methylation and CpG, TpG (CpA) and TpA frequencies.

Authors:  Kamel Jabbari; Giorgio Bernardi
Journal:  Gene       Date:  2004-05-26       Impact factor: 3.688

10.  MicroRNA-17-92, a direct Ap-2α transcriptional target, modulates T-box factor activity in orofacial clefting.

Authors:  Jun Wang; Yan Bai; Hong Li; Stephanie B Greene; Elzbieta Klysik; Wei Yu; Robert J Schwartz; Trevor J Williams; James F Martin
Journal:  PLoS Genet       Date:  2013-09-19       Impact factor: 5.917

View more
  2 in total

Review 1.  The RNA-binding fragile-X mental retardation protein and its role beyond the brain.

Authors:  Cassandra Malecki; Brett D Hambly; Richmond W Jeremy; Elizabeth N Robertson
Journal:  Biophys Rev       Date:  2020-07-11

Review 2.  Rare Causes of Arterial Hypertension and Thoracic Aortic Aneurysms-A Case-Based Review.

Authors:  Svetlana Encica; Adrian Molnar; Simona Manole; Teodora Filan; Simona Oprița; Eugen Bursașiu; Romana Vulturar; Laura Damian
Journal:  Diagnostics (Basel)       Date:  2021-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.